bristol-myers squibb

Credit Suisse reviewed its stances on major U.S. pharma names in a note this week, though the analysts came to the same conclusion that Bristol-Myers Squibb Co (NYSE: BMY) and Pfizer Inc (NYSE: PFE) were the best in class. The analysts also noted that they have an Outperform rating on AbbVie Inc...

Bristol-Myers Squibb Co (NYSE: BMY) was more than 3 percent higher in early trading after the company announced that Phase III study of Opdivo was stopped early after the trial "met its endpoint," according to a press release from the company. Opdivo "demonstrated superior...

When it comes to the search for Ebola treatments, names like BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX), Chimerix Inc (NASDAQ: CMRX), Sarepta Therapeutics Inc (NASDAQ: SRPT) and Tekmira Pharmaceuticals Corporation (NASDAQ: TKMR) have cropped up frequently. Could these or other biotech companies...

U.S. stocks were little changed with the S&P 500 closing for the second straight day above the 2,000 mark. Markets were on track for a flat open and volume and volatility remained relatively light throughout the trading session as geopolitical events remain in focus. Israel and Gaza have...

U.S. markets managed to squeeze out small gains in lighter than normal volume, as geopolitical tensions may be calming down. Russia President Vladimir Putin said that the country will coordinate with the International Red Cross to send humanitarian aid to Ukraine. Meanwhile, Palestinians and...

U.S. stocks rose as earning season unofficially kicked off with Citigroup reporting better than expected earnings. The Dow Jones Industrial average set new intra-day records, hitting an all time high of 17,088.43 as investors appear to be comfortable with holding blue chips instead of...

The earnings crunch continues this week. Among the highlights will be scheduled quarterly reports from Exxon Mobil and Chevron, from Bristol-Myers Squibb and Merck, from Time Warner and Viacom, and also from Twitter. Early Thursday, Exxon Mobil (NYSE: XOM) is expected to say that it had earnings...

U.S. stocks fell on Tuesday as investors found a decline in consumer confidence as reason enough to keep stocks from moving higher. The S&P 500 retreated from its record all time high set yesterday but took a run above the 1,850 level in the late morning. The all time high for the index is...

The markets are closed on Monday for Martin Luther King Day, but after that the earnings season shifts back into high gear. The consensus forecasts for eBay, McDonald's, Netflix, Starbucks and Verizon call for year-over-year growth in per-share earnings. But analysts are looking for declining...

Major indices received a boost in Friday's trading activity following a better than expected third quarter GDP. The surprising economic data is yet another key data that may suggests that the economy is healthy enough and could handle the Fed's recent decision to taper its bond buying program....

Major indices barely budged Thursday following yesterday's monster rally after the Fed announced it will begin tapering. Overall volume was below average which is typical in the final trading days of the year. Next week will be shortened as investors break for Christmas and a week later for new...

Lots of quarterly reports are on deck this week, to go along with all the delayed economic data expected to be released. Analysts and investors should have plenty to mull over. Earnings highlights will include reports from AT&T, McDonald's, Microsoft and Netflix, which are all expected to post...

Among leading biotech and emerging pharmaceutical companies, short sellers moved on Amgen (NASDAQ: AMGN), Pharmacyclics (NASDAQ: PCYC) and Vertex Pharmaceuticals (NASDAQ: VRTX) the most strongly in late September. The number of shares sold short in Dendreon (NASDAQ: DNDN) and Biogen Idec (NASDAQ:...